IgA Nephropathy FAQ
IgA Nephropathy FAQ
This page answers only the practical questions — what to send, what happens here, when travelling should be postponed, what it costs and how it is paid for, and how care continues afterwards. Every clinical question is answered by the other six pages in this guide, and this page does not repeat them.
What it costs
The initial assessment is free: records sent ahead are reviewed without charge, and the written opinion — including whether assessment here would add anything to the care you already receive — comes back before any payment is discussed. That ordering is deliberate. A large share of the enquiries we receive are answered in that letter, and no travel follows.
Where treatment here is appropriate, complete care in China typically runs at 30–50% of comparable care in Europe or the United States, consistently across conditions and programmes. For IgA nephropathy the components are the assessment and its investigations — urine studies, blood tests, imaging and, where indicated, a kidney biopsy with immunofluorescence and electron microscopy — followed by the medicines prescribed and the follow-up measurements. An itemised quotation is provided once the records define what is actually needed, because a patient who already holds a scored biopsy report needs far less than one whose diagnosis has never been established. What this page will not do is give a price without that: the range depends entirely on which of those applies.
How long the visit takes
This is stated in the written plan before anything is booked, because it depends on what the assessment turns up rather than on a standard package. An assessment built around urine and blood testing, imaging and consultation is arranged as outpatient visits and can be completed in a short stay. Where the findings call for a kidney biopsy, an extra day of observation is built in — the procedure itself is short, and the monitoring afterwards is what takes the time.
For patients whose reason for travelling is not the kidney disease, the assessment is fitted around the visit rather than the other way round. Families commonly add time either side for travel and a settling consultation; the plan states the expected total before booking so that flights and visas are arranged against a number rather than an estimate.
Which records to send
Five groups of documents decide most of the assessment, and none requires translation beyond what our coordinators handle.
| What to send | What it answers |
|---|---|
| Urine results with dates — microscopy and protein | Whether the blood is coming through the filter, and whether protein is being lost and at what level |
| Creatinine and filtration readings, ideally a series | Where you are on the trajectory, and whether it is moving. Three readings over six months are worth more than one precise one |
| The biopsy report, if one exists | The diagnosis, and the Oxford score — which is what decides whether immune therapy is even a question |
| Blood pressure readings, including home ones | Whether the most treatable driver is controlled, and on how much medicine |
| Full medicines list, including over-the-counter and supplements | Whether something being taken regularly is stressing the kidney, and what can be substituted |
Add the history of the conditions that travel with this one — hypertension, diabetes, liver disease, coeliac disease, inflammatory bowel disease, any chronic infection — and, if you have them, the results of any coeliac or hepatitis screening already done. Photographs of clinic letters are acceptable to start. Where the protein has only ever been measured once, or always during an infection, the opinion says so and names the tests to arrange locally first.
When travelling is safe — and when it is not
Postpone travel during visible haematuria with fever, until infection has been excluded; with new swelling and reduced urine output, which suggests an acute injury on top of chronic disease; during any acute illness with dehydration; and in the days immediately after a kidney biopsy, until the post-procedure observation period is complete and the immediate results are known. These are not administrative cautions — each is a state in which the assessment here would be distorted by the acute problem, or in which the flight itself carries real risk.
For everyone else, travelling with this condition is routine with a few disciplines. Carry medicines in hand luggage, never in the hold, and carry more than the trip appears to need, split between two bags. Carry a doctor's letter covering the condition and the medicines — useful at a border and essential if you need care away from your own team. Drink water on a long flight and move regularly. And know what to stop during a febrile illness: that plan is written into the summary you take home, and it is worth reading before you need it.
Insurance and payment
We work with more than 30 commercial insurers on direct billing. Coordinators confirm coverage, exclusions and the paperwork required before arrival rather than after it — which matters here, because a kidney assessment that turns out to need a biopsy costs rather more than one that does not, and the pre-authorisation should cover the possibility.
Patients without suitable coverage receive an itemised quotation and pay directly. Either way, costs are agreed in writing before travel, and the records review itself is free and happens first. Where an insurer requires a specific form or clinical letter, our department completes it as part of the assessment rather than as a billable extra.
What happens after you go home
You leave with a written summary in English covering the diagnosis and how it was established, the Oxford score if a biopsy was performed, the proteinuria and blood pressure targets that apply in your case, the medicines and what each is for, the monitoring intervals, and a sick-day plan. Laboratory and pathology data, including the biopsy report, are exported in standard formats so that your local team continues the same series rather than starting a new one.
Continuity is the part that usually fails in cross-border care, so it is arranged explicitly: our international department remains a written point of contact for questions about the opinion, and will correspond with your local doctor when that is useful. Where a treatment started here needs monitoring that only your local team can provide, the letter says what to measure and when, in terms any laboratory will recognise.
Follow-up also works by correspondence. A patient who sends protein, creatinine and blood pressure readings every few months can have the trajectory reviewed without travelling, and the question of whether immune therapy has become indicated is answered from that series rather than from a single visit.
Coming with someone, and staying nearby
Most patients travel with a companion, and for an assessment that may include a biopsy it is worth doing so: the procedure itself is short, but a day of observation afterwards is more comfortable with someone present, and a second person hearing the plan is worth more than a written summary alone. Our international department arranges visa invitation letters, airport transfer and accommodation near the hospital, and interprets in the clinic and for the consent discussion rather than only for the consultation.
For families, the practical shape is a short assessment block at the start, then whatever the findings call for, then a settling period before flying home. The expected total is written into the plan before anything is booked, so that flights, visas and a companion's leave are all arranged against the same number.